Skip Navigation
Skip to contents

Ann Coloproctol : Annals of Coloproctology

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
1 "Taeyeong Eom"
Filter
Filter
Article category
Keywords
Publication year
Authors
Display
Original Article
Malignant disease,Prognosis and adjuvant therapy,Colorectal cancer
Prognostic Factors Affecting Disease-Free Survival and Overall Survival in T4 Colon Cancer
Taeyeong Eom, Yujin Lee, Jungbin Kim, Inseok Park, Geumhee Gwak, Hyunjin Cho, Keunho Yang, Kiwhan Kim, Byung-Noe Bae
Ann Coloproctol. 2021;37(4):259-265.   Published online June 24, 2021
DOI: https://doi.org/10.3393/ac.2020.00759.0108
Correction in: Ann Coloproctol 2023;39(5):444
  • 7,145 View
  • 109 Download
  • 19 Web of Science
  • 19 Citations
AbstractAbstract PDF
Purpose
It is known that as the T stage of a carcinoma progresses, the prognosis becomes poorer. However, there are few studies about factors that affect the prognosis of T4 advanced colon cancer. This study aimed to identify the prognostic factors associated with disease-free survival (DFS) and overall survival (OS) in T4 colon cancer.
Methods
Patients diagnosed with stage T4 on histopathology after undergoing curative surgery for colon cancer between March 2009 and March 2018 were retrospectively analyzed for factors related to postoperative survival. Primary outcomes were DFS and OS.
Results
Eighty-two patients were included in the study. DFS and OS of the pathologic (p) T4b group were not inferior to that of the pT4a group. Multivariate analysis showed that differentiation (hazard ratio [HR], 4.994; P = 0.005), and laparoscopic surgery (HR, 0.323; P = 0.008) were significant prognostic factors for DFS, while differentiation (HR, 7.904; P ≤ 0.001) and chemotherapy (HR, 0.344; P = 0.038) were significant prognostic factors for OS.
Conclusion
Tumor differentiation, laparoscopic surgery, and adjuvant chemotherapy were found to be significant prognostic factors in patients with T4 colon cancer. Adjuvant chemotherapy and curative resections by laparoscopy might improve the prognosis in these patients.

Citations

Citations to this article as recorded by  
  • Tailored-surgery for locally advanced colon cancer based on 3D mathematical reconstruction surgical planner: Observational comparative non-randomized study
    Sebastián Jerí-McFarlane, Álvaro García-Granero, Marco Antonio Martínez-Ortega, Isabel Amengual-Antich, Ángela Rodríguez Robayo, Margarita Gamundí-Cuesta, Francisco Xavier González-Argenté
    European Journal of Surgical Oncology.2025; 51(2): 109584.     CrossRef
  • Prognostic Factors of Postoperative Mortality in Patients with Complicated Right Colon Cancer
    Raul Mihailov, Corina Dima, Bianca Georgiana Constantin, Florentin Dimofte, Mihaela Craescu, Lavinia Moroianu, Laura Iuliana Candussi, Virginia Lutenco, Oana Mariana Mihailov, Valerii Lutenco
    Life.2025; 15(3): 350.     CrossRef
  • The impact of sarcopenic obesity on the prevalence and prognosis of non-metastatic colorectal cancer: A systematic review and meta-analysis
    Wanping Wang, Fang Fang, Tianxiu Wang, Xinyi Chen, Lu Zhao, Chunmei Wang, Yujia Tang, Qin Li, Dong Tang, Jingqiu Zhang
    Clinical Nutrition ESPEN.2025; 69: 492.     CrossRef
  • Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus R0 resection for resectable colorectal cancer with peritoneal metastases and low peritoneal cancer index scores: a collaborative observational study from Korea and Japan
    Daichi Kitaguchi, Eun Jung Park, Seung Hyuk Baik, Shoma Sasaki, Yuichiro Tsukada, Masaaki Ito
    International Journal of Surgery.2024; 110(1): 45.     CrossRef
  • Cytotoxicity of Salvigenin from Asterohyptis stellulata in Combination with Clinical Drugs Against Colorectal Cancer
    Briand André Rojas-Castaño, Adriana C. Hernández-Rojas, Rogelio Pereda-Miranda, Mabel Fragoso-Serrano
    Revista Brasileira de Farmacognosia.2024; 34(5): 1172.     CrossRef
  • Sorbate metal complexes as newer antibacterial, antibiofilm, and anticancer compounds
    Amira I. Abousaty, Fifi M. Reda, Wessam A. Hassanin, Walaa M. Felifel, Walaa H. El-Shwiniy, Heba M. R. M. Selim, Mahmoud M. Bendary
    BMC Microbiology.2024;[Epub]     CrossRef
  • The Association Between Surgical Site Infection and Prognosis of T4 Colorectal Cancer
    Takuya Koike, Masaya Mukai, Kyoko Kishima, Daiki Yokoyama, Sayuri Hasegawa, Lin Fung Chan, Hideki Izumi, Kazutake Okada, Tomoko Sugiyama, Takuma Tajiri
    Cureus.2024;[Epub]     CrossRef
  • Utilizing stimuli-responsive nanoparticles to deliver and enhance the anti-tumor effects of bilirubin
    Elaheh Mirhadi, Alexandra E. Butler, Prashant Kesharwani, Amirhossein Sahebkar
    Biotechnology Advances.2024; 77: 108469.     CrossRef
  • Can clinicopathologic high-risk features in T3N0 colon cancer be reliable prognostic factors?
    Hyun Gu Lee, Young IL Kim, In Ja Park, Seok-Byung Lim, Chang Sik Yu
    Annals of Surgical Treatment and Research.2023; 104(2): 109.     CrossRef
  • Clinical implication of tissue carcinoembryonic antigen expression in association with serum carcinoembryonic antigen in colorectal cancer
    Abdulmohsin Fawzi Aldilaijan, Young Il Kim, Chan Wook Kim, Yong Sik Yoon, In Ja Park, Seok-Byung Lim, Jihun Kim, Jun-Soo Ro, Jin Cheon Kim
    Scientific Reports.2023;[Epub]     CrossRef
  • Do Laparoscopic Approaches Ensure Oncological Safety and Prognosis for Serosa-Exposed Colon Cancer? A Comparative Study against the Open Approach
    Ji-Hyun Seo, In-Ja Park
    Cancers.2023; 15(21): 5211.     CrossRef
  • Erratum to “Prognostic factors affecting disease-free survival and overall survival in T4 colon cancer”

    Annals of Coloproctology.2023; 39(5): 444.     CrossRef
  • Inflammatory Response Markers as Predictors of Colorectal Cancer Prognosis
    Minsung Kim, Il Tae Son, Bo Young Oh
    The Ewha Medical Journal.2023;[Epub]     CrossRef
  • The Prognostic Reliability of Lymphovascular Invasion for Patients with T3N0 Colorectal Cancer in Adjuvant Chemotherapy Decision Making
    Hayoung Lee, Seung-Yeon Yoo, In Ja Park, Seung-Mo Hong, Seok-Byung Lim, Chang Sik Yu, Jin Cheon Kim
    Cancers.2022; 14(12): 2833.     CrossRef
  • Molecular analyses of peritoneal metastasis from colorectal cancer
    Chang Hyun Kim
    Journal of the Korean Medical Association.2022; 65(9): 586.     CrossRef
  • Molecular Analyses in Peritoneal Metastasis from Colorectal Cancer: A Review-An English Version
    Chang Hyun Kim
    Journal of the Anus, Rectum and Colon.2022; 6(4): 197.     CrossRef
  • Impact on inadequate lymph node harvest on survival in T4N0 colorectal cancer: A would-be medical center experience in Taiwan
    Yi-Kai Kao, Hsin-Pao Chen, Kuang-Wen Liu, Ling-Chiao Song, Yi-Chieh Chen, Yu-Chun Lin, Chih-I Chen
    Medicine.2022; 101(52): e32497.     CrossRef
  • Prognostic risk factors for pT4 colon cancer: A retrospective cohort study
    Tsutomu Kumamoto, Shigeki Yamaguchi, Ryosuke Nakagawa, Yoji Nagashima, Fumi Maeda, Kimitaka Tani, Hiroka Kondo, Kurodo Koshino, Yuka Kaneko, Yoshiko Bamba, Shimpei Ogawa, Yuji Inoue, Michio Itabashi
    Oncology Letters.2022;[Epub]     CrossRef
  • Antiproliferative and palliative activity of flavonoids in colorectal cancer
    Javier Fernández, Blanca Silván, Rodrigo Entrialgo-Cadierno, Claudio J. Villar, Raffaele Capasso, José Antonio Uranga, Felipe Lombó, Raquel Abalo
    Biomedicine & Pharmacotherapy.2021; 143: 112241.     CrossRef
  • FirstFirst
  • PrevPrev
  • Page of 1
  • Next Next
  • Last Last

Ann Coloproctol : Annals of Coloproctology Twitter Facebook
TOP